Answering the unanswered questions: ongoing trials of statins and antihypertensives in type 2 diabetes R. Scott Pages: s46 - s51
Evolving therapeutic strategies for retarding progression of diabetic nephropathy – an update for 2002 M. Epstein Pages: s41 - s45
Impact of the atherosclerotic process in patients with diabetes R. W. NestoM. K. Rutter Pages: s22 - s28